Synaptogenix Backs $100M AI Crypto Pivot, Taps Altucher to Lead
Synaptogenix is making a bold strategic shift, pivoting from its biotech roots to embrace the convergence of artificial intelligence and blockchain. The company announced plans to acquire up to $100 million worth of Bittensor’s TAO, currently the leading AI-focused...